» Articles » PMID: 32943575

Deubiquitinase USP20 Promotes Breast Cancer Metastasis by Stabilizing SNAI2

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2020 Sep 18
PMID 32943575
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

SNAI2/SLUG, a metastasis-promoting transcription factor, is a labile protein that is degraded through the ubiquitin proteasome degradation system. Here, we conducted comprehensive gain- and loss-of-function screens using a human DUB cDNA library of 65 genes and an siRNA library of 98 genes, and identified USP20 as a deubiquitinase (DUB) that regulates SNAI2 ubiquitination and stability. Further investigation of USP20 demonstrated its function in promoting migration, invasion, and metastasis of breast cancer. USP20 positively correlates with SNAI2 protein level in breast tumor samples, and higher USP20 expression is associated with poor prognosis in ER breast cancer patients.

Citing Articles

Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies.

Du Y, Yang Y, Zheng B, Zhang Q, Zhou S, Zhao L Oncogene. 2025; 44(7):409-426.

PMID: 39863748 PMC: 11810799. DOI: 10.1038/s41388-025-03273-8.


Integrating RNA-seq and scRNA-seq to explore the prognostic features and immune landscape of exosome-related genes in breast cancer metastasis.

Huang G, Yu Y, Su H, Gan H, Chu L Ann Med. 2025; 57(1):2447917.

PMID: 39847423 PMC: 11758802. DOI: 10.1080/07853890.2024.2447917.


The Clinical Prediction Value of the Ubiquitination Model Reflecting the Microenvironment Infiltration and Drug Sensitivity in Breast Cancer.

Ma H, Cao J, Zhang Y, Yang J, Wang X, Yu Y J Cancer. 2025; 16(3):784-801.

PMID: 39781342 PMC: 11705054. DOI: 10.7150/jca.101525.


Deubiquitinases as novel therapeutic targets for diseases.

Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W MedComm (2020). 2024; 5(12):e70036.

PMID: 39678489 PMC: 11645450. DOI: 10.1002/mco2.70036.


USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1.

Chen W, Wu S, Chen Y, Li W, Cao Y, Liang Y Neoplasia. 2024; 60:101102.

PMID: 39674114 PMC: 11699748. DOI: 10.1016/j.neo.2024.101102.


References
1.
Manasanch E, Orlowski R . Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017; 14(7):417-433. PMC: 5828026. DOI: 10.1038/nrclinonc.2016.206. View

2.
Minn A, Gupta G, Siegel P, Bos P, Shu W, Giri D . Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436(7050):518-24. PMC: 1283098. DOI: 10.1038/nature03799. View

3.
Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H . Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2014; 6(2):979-94. PMC: 4359269. DOI: 10.18632/oncotarget.2825. View

4.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

5.
Komander D, Clague M, Urbe S . Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009; 10(8):550-63. DOI: 10.1038/nrm2731. View